[go: up one dir, main page]

WO2001075055A3 - A novel polypeptide, human quinoprotein reductase 9 and the polynucleotide encoding the polypeptide - Google Patents

A novel polypeptide, human quinoprotein reductase 9 and the polynucleotide encoding the polypeptide Download PDF

Info

Publication number
WO2001075055A3
WO2001075055A3 PCT/CN2001/000520 CN0100520W WO0175055A3 WO 2001075055 A3 WO2001075055 A3 WO 2001075055A3 CN 0100520 W CN0100520 W CN 0100520W WO 0175055 A3 WO0175055 A3 WO 0175055A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptide
polynucleotide encoding
quinoprotein reductase
human
human quinoprotein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2001/000520
Other languages
French (fr)
Chinese (zh)
Other versions
WO2001075055A2 (en
Inventor
Yumin Mao
Yi Xie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Biowindow Gene Development Inc
Original Assignee
Shanghai Biowindow Gene Development Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Biowindow Gene Development Inc filed Critical Shanghai Biowindow Gene Development Inc
Priority to AU73777/01A priority Critical patent/AU7377701A/en
Publication of WO2001075055A2 publication Critical patent/WO2001075055A2/en
Publication of WO2001075055A3 publication Critical patent/WO2001075055A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0012Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0036Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention disclosed a new kind of human quinoprotein reductase 9 and the polynucleotide encoding said polypeptide and a process for producing the polypeptide by recombinant methods. It also disclosed the methods of applying the polypeptide for the treatment of various kinds of diseases, such as cancer, hemopathy, HIV infection, immune diseases and inflammation. The antagonist of the polypeptide and therapeutic use of the same is also disclosed. In addition, it refers to the use of polynucleotide encoding said human quinoprotein reductase 9.
PCT/CN2001/000520 2000-03-29 2001-03-26 A novel polypeptide, human quinoprotein reductase 9 and the polynucleotide encoding the polypeptide Ceased WO2001075055A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU73777/01A AU7377701A (en) 2000-03-29 2001-03-26 A novel polypeptide, human quinine reductase 9 and the polynucleotide encoding the polypeptide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN00115266.1 2000-03-29
CN00115266A CN1315529A (en) 2000-03-29 2000-03-29 Polypeptide-human quinoprotein reductase 9 and polynucleotide for coding it

Publications (2)

Publication Number Publication Date
WO2001075055A2 WO2001075055A2 (en) 2001-10-11
WO2001075055A3 true WO2001075055A3 (en) 2002-04-18

Family

ID=4584734

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000520 Ceased WO2001075055A2 (en) 2000-03-29 2001-03-26 A novel polypeptide, human quinoprotein reductase 9 and the polynucleotide encoding the polypeptide

Country Status (3)

Country Link
CN (1) CN1315529A (en)
AU (1) AU7377701A (en)
WO (1) WO2001075055A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998057662A2 (en) * 1997-06-14 1998-12-23 Enzacta R & D Limited Therapeutic systems

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998057662A2 (en) * 1997-06-14 1998-12-23 Enzacta R & D Limited Therapeutic systems

Also Published As

Publication number Publication date
CN1315529A (en) 2001-10-03
WO2001075055A2 (en) 2001-10-11
AU7377701A (en) 2001-10-15

Similar Documents

Publication Publication Date Title
WO2001075055A3 (en) A novel polypeptide, human quinoprotein reductase 9 and the polynucleotide encoding the polypeptide
WO2001075030A3 (en) A novel polypeptide - human tyrosinase 11 and the polynucleotide encoding said polypeptide
WO2001074993A3 (en) A novel polypeptide - human zinc finger protein 17 and the polynucleotide encoding said polypeptide
WO2001079436A3 (en) A novel polypeptide - human cell differentiation transcription factor 10 and the polynucleotide encoding said polypeptide
WO2001079430A3 (en) A novel polypeptide - human serine protease 9 and the polynucleotide encoding said polypeptide
WO2001075041A3 (en) A novel polypeptide-human epilepsy-associated protein 11 and the polynucleotide encoding said polypeptide
WO2001075038A3 (en) A novel polypeptide - human atp- dependent serine protease 9 and the polynucleotide encoding said polypeptide
WO2001079429A3 (en) A novel polypeptide - human guanine nucleotide exchange factor 10and the polynucleotide encoding said polypeptide
WO2001083677A3 (en) A novel polypeptide- human chiken limb deformity protein fh12-13 and the polynucleotide encoding said polypeptide
WO2001045729A8 (en) A novel polypeptide-human ribosomal phosphoprotein 16 and the polynucleotide encoding said polypeptide
WO2001079423A3 (en) A novel polypeptide, human bcr protein 10 and the polynucleotide encoding said polypeptide
WO2001083758A3 (en) A novel polypeptide- human dihydroorotase 8 and the polynucleotide encoding said polypeptide
WO2001075045A3 (en) A novel polypeptide - human clathrin light chain 17 and the polynucleotide encoding said polypeptide
WO2001075036A3 (en) A novel polypeptide, human immunophiline 14 and the polynucleotide encoding the polypeptide
WO2001079425A3 (en) A novel polypeptide - human chloride channel protein 10 and the polynucleotide encoding said polypeptide
WO2001075016A3 (en) A novel polypeptide, a human tyrosinase 16, and the polynucleotide encoding the polypeptide
WO2002008427A1 (en) A NOVEL POLYPEPTIDE- HUMAN Na+/K+ PUMP 9.57 AND THE POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE
WO2001075044A3 (en) A novel polypeptide- human ribosomal protein s18-18 and the polynucleotide encoding said polypeptide
WO2001083676A3 (en) A novel polypeptide human strip-riched phosphatase 10 and the polynucleotide encoding said polypeptide
WO2001075019A3 (en) A novel polypeptide - human ataxia - telangiectasia mutein 11 andthe polynucleotide encoding said polypeptide
WO2001079424A3 (en) A novel polypeptide - human mitochondrial atpase coupling facor 6-10 and the polynucleotide encoding said polypeptide
WO2001075062A3 (en) A novel polypeptide, human hydrogenase 10 and the polynucleotide encoding the polypeptide
WO2001075018A3 (en) A novel polypeptide, a human regulation factor of transcription 31 and the polynucleotide encoding the polypeptide
WO2001083680A3 (en) A novel polypeptide- human phosphoribosyl glycinamide synthase 11 and the polynucleotide encoding said polypeptide
WO2001075048A3 (en) A novel polypeptide, human ribosomal protein s11 23 and the polynucleotide encoding the polypeptide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP